SLC5A1 and heart failure: In addition (Figure 1), they can improve cardiac function in patients with heart failure by decreasing the circulating volume load, regulating energy metabolism, maintaining ionic homeostasis, mitigating inflammation and oxidative stress, directly inhibiting cardiac SGLT1 receptors, and enhancing antimyocardial fibrotic effects.